Kerrie Eldredge

Kerrie Eldredge has a diverse and extensive work experience in the pharmaceutical industry. Kerrie started their career in 1997 as a Territory Sales Representative at Forest Laboratories (now Allergan) and later worked as a Specialty Sales Representative at Forest Pharmaceuticals from 2000 to 2006. At Forest Labs, they served as a Hospital Account Manager from 2006 to 2013, where they achieved growth goals for various medications.

In 2013, Kerrie joined Allergan as a Long Term Care Account Manager, responsible for managing national chain skilled nursing facilities and assisted living homes. Kerrie successfully launched multiple medications, including dementia medications, IBS/CC medication, and COPD products. Kerrie'srole involved working with psychiatry, neurology, medical directors, long-term care pharmacy owners, pharmacists, facility administrators, and directors of nursing.

In 2016, Kerrie joined Acadia Pharmaceuticals Inc. as an Executive Long Term Care Account Manager. Kerrie played a crucial role in the commercial launch of ACADIA Pharmaceuticals' first therapy approved for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis. Kerrie'sresponsibilities included launching a new diagnosis and treatment option across various medical professionals. Kerrie later transitioned to the role of Executive Neuroscience Sales Specialist.

Additionally, Kerrie held a position as West Coast LTC Regional Sales Trainer at Acadia Pharmaceuticals from 2017 to 2021. Throughout their career, they have consistently demonstrated strong sales and account management skills in the pharmaceutical industry.

Kerrie Eldredge attended Loyola Marymount University from 1987 to 1991, where they pursued a Bachelor of Business Administration (B.B.A.) degree in Business Administration and Management, General.